Which statement best describes the cancer-associated phenotype of Fusobacterium spp?

Study for the ACVIM Small Animal Internal Medicine Exam to enhance your veterinary knowledge. Prepare with flashcards and multiple-choice questions, featuring hints and explanations. Ensure success in your exam journey!

Multiple Choice

Which statement best describes the cancer-associated phenotype of Fusobacterium spp?

Explanation:
The cancer-associated phenotype of Fusobacterium spp is characterized by a pro-inflammatory, adhesive/invasive behavior that can promote tumor development and progression. In species like Fusobacterium nucleatum, adhesins such as FadA allow the bacteria to attach to and invade colonic epithelial cells, binding to E-cadherin and activating beta-catenin signaling. This drives transcription of oncogenic and proliferative genes, contributing to tumor growth. At the same time, the bacteria stimulate a pro-inflammatory environment by engaging pathways such as NF-κB and increasing cytokines like IL-6 and IL-8, which can recruit immune cells in a way that supports tumor progression and may dampen anti-tumor immunity. This combination—adhesive/invasive capacity plus pro-inflammatory, pro-oncogenic signaling—best describes their cancer-associated phenotype. It is not anti-inflammatory, not non-pathogenic, and its impact goes beyond metabolism to directly influence cancer signaling and the tumor microenvironment.

The cancer-associated phenotype of Fusobacterium spp is characterized by a pro-inflammatory, adhesive/invasive behavior that can promote tumor development and progression. In species like Fusobacterium nucleatum, adhesins such as FadA allow the bacteria to attach to and invade colonic epithelial cells, binding to E-cadherin and activating beta-catenin signaling. This drives transcription of oncogenic and proliferative genes, contributing to tumor growth. At the same time, the bacteria stimulate a pro-inflammatory environment by engaging pathways such as NF-κB and increasing cytokines like IL-6 and IL-8, which can recruit immune cells in a way that supports tumor progression and may dampen anti-tumor immunity. This combination—adhesive/invasive capacity plus pro-inflammatory, pro-oncogenic signaling—best describes their cancer-associated phenotype. It is not anti-inflammatory, not non-pathogenic, and its impact goes beyond metabolism to directly influence cancer signaling and the tumor microenvironment.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy